Encequidar (HM30181) mesylate hydrochloride is a potent and selective inhibitor of P-glycoprotein (MDR1). Encequidar mesylate hydrochloride improves anti-tumor efficacy of Paclitaxel (HY-B0015) in mouse tumor models[1][2][3].
Molecular Weight:
802.85
CAS Number:
[2097125-58-9]
Formula:
C39H42N6O11S
Target:
P-glycoprotein
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted